Enhancing immunotherapy efficacy with synergistic low-dose radiation in metastatic melanoma: current insights and prospects.

导出 OA

翻译打印收藏纠错

作者： Zahid,Rafiq ^[1] ; Mingyo,Kang ^[2] ; Hampartsoum B,Barsoumian ^[2] ; Gohar S,Manzar ^[2] ; Yun,Hu ^[2] ; Carola,Leuschner ^[2] ; Ailing,Huang ^[2] ; Fatemeh,Masrorpour ^[2] ; Weiqin,Lu ^[3] ; Nahum,Puebla-Osorio ^[4] ; James W,Welsh ^[5]

作者单位： Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.;Department of Pharmaceutical Sciences, School of Pharmacy, University of Texas at El Paso, 500 W. University Ave, El Paso, TX, 79968, USA. ^[1] Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. ^[2] Department of Pharmaceutical Sciences, School of Pharmacy, University of Texas at El Paso, 500 W. University Ave, El Paso, TX, 79968, USA. ^[3] Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. npuebla@mdanderson.org. ^[4] Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. jwelsh@mdanderson.org. ^[5]

主题词人类(Humans);黑色素瘤(Melanoma);免疫疗法(Immunotherapy);综合疗法(Combined Modality Therapy);肿瘤转移(Neoplasm Metastasis)

DOI 10.1186/s13046-025-03281-2

PMID 39881333

发布时间 2025-02-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交